APA (7th ed.) Citation

Shih, A. W., Yan, M. T., Elahie, A. L., Barty, R. L., Liu, Y., Berardi, P., . . . Verhovsek, M. M. (2020). Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk‐stratify patients for alloimmunisation risk. Transfusion Medicine, 30(4), 263. https://doi.org/10.1111/tme.12685

Chicago Style (17th ed.) Citation

Shih, Andrew W., et al. "Utilising Red Cell Antigen Genotyping and Serological Phenotyping in Sickle Cell Disease Patients to Risk‐stratify Patients for Alloimmunisation Risk." Transfusion Medicine 30, no. 4 (2020): 263. https://doi.org/10.1111/tme.12685.

MLA (9th ed.) Citation

Shih, Andrew W., et al. "Utilising Red Cell Antigen Genotyping and Serological Phenotyping in Sickle Cell Disease Patients to Risk‐stratify Patients for Alloimmunisation Risk." Transfusion Medicine, vol. 30, no. 4, 2020, p. 263, https://doi.org/10.1111/tme.12685.